EUVIMEDEUVIMED entdecken
Crossref

Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures

Digestive Endoscopology Branch of Chinese Medical Association, Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, National Clinical Research Center for Digestive Diseases (Shanghai)

Journal of Digestive Diseases · 2024

DOI: 10.1111/1751-2980.13248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2024. Verfasst von Digestive Endoscopology Branch of Chinese Medical Association und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ampulla of Vater, Bile Duct Neoplasms, Common Bile Duct Neoplasms, Cholestasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopy‐guided endobiliary radiofrequency ablation has emerged as a novel treatment for malignant biliary strictures in recent years. When combined with biliary stenting and systemic chemotherapy, it can effectively postpone local tumor progression, improve patient's quality of life, and prolong their survival, which is mainly indicated for patients with inoperable extrahepatic cholangiocarcinoma and ampullary cancer. Based on the existing clinical evidence, the Digestive Endoscopology Branch of Chinese Medical Association, the Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, and the National Clinical Research Center for Digestive Diseases (Shanghai) organized relevant experts to discuss the indications, contraindications, technical operation specifications, and prevention and treatment of the complications during endoscopy‐guided endobiliary radiofrequency ablation. Consensus statements were established, trying to provide references for standard treatment of malignant biliary tumors in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ampulla of VaterBile Duct NeoplasmsCommon Bile Duct NeoplasmsCholestasisRadiofrequency AblationCatheter AblationHumansConstriction, PathologicQuality of LifeChinaEndoscopy, GastrointestinalStentsBile Ducts, IntrahepaticCholangiopancreatography, Endoscopic RetrogradeTreatment Outcome

Stichwörter der Autor:innen

consensusendoscopic retrograde cholangiopancreatographymalignant biliary strictureradiofrequency ablation

Zitieren

APA

Digestive Endoscopology Branch of Chinese Medical Association, Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, & National Clinical Research Center for Digestive Diseases (Shanghai) (2024). Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13248

Vancouver

Digestive Endoscopology Branch of Chinese Medical Association, Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, National Clinical Research Center for Digestive Diseases (Shanghai). Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures. Journal of Digestive Diseases. 2024. doi:10.1111/1751-2980.13248

BibTeX
@article{DigestiveEndoscopologyBranchofChineseMedicalAssociation2024,
  author = {Digestive Endoscopology Branch of Chinese Medical Association, Digestive Endoscopology Branch of Chinese Medical Association and Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association, Digestive Endoscopy Professional Committee, Endoscopic Physicians Branch of Chinese Medical Doctor Association and National Clinical Research Center for Digestive Diseases (Shanghai), National Clinical Research Center for Digestive Diseases (Shanghai)},
  title = {Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures},
  journal = {Journal of Digestive Diseases},
  year = {2024},
  doi = {10.1111/1751-2980.13248}
}
Kostenlos starten →